Provided by Tiger Fintech (Singapore) Pte. Ltd.

FibroGen

0.3001
-0.0098-3.16%
Post-market: 0.3000-0.0001-0.03%19:26 EDT
Volume:911.97K
Turnover:284.43K
Market Cap:30.29M
PE:-0.63
High:0.3310
Open:0.3021
Low:0.3000
Close:0.3099
Loading ...

FibroGen Announces Publication of Results From Phase 1 Monotherapy Study of FG-3246 in Patients With Metastatic Castration-Resistant Prostate Cancer in the Journal of Clinical Oncology

THOMSON REUTERS
·
28 Mar

FibroGen Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
19 Mar

FibroGen Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
18 Mar

Q4 2024 FibroGen Inc Earnings Call

Thomson Reuters StreetEvents
·
18 Mar

FibroGen Announces Strategic Sale and Financial Outlook

TIPRANKS
·
18 Mar

FibroGen Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
18 Mar

FibroGen Q4 EPS From Continuing Operations $(0.08), Revenue From Continuing Operations $3.100M

Benzinga
·
18 Mar

FibroGen Inc: Qtrly Net Income per Share $0.18

THOMSON REUTERS
·
18 Mar

FibroGen options imply 18.1% move in share price post-earnings

TIPRANKS
·
18 Mar

FibroGen Inc expected to post a loss of 14 cents a share - Earnings Preview

Reuters
·
15 Mar

FGEN Enhances Share Capital Management with Treasury Share Purchase

TIPRANKS
·
05 Mar

BRIEF-FibroGen Says Entered ATM Equity Offering Sales Agreement Relating To Sale From Time To Time Of Shares Of Common Stock

Reuters
·
25 Feb

FibroGen Inc - Entered Atm Equity Offering Sales Agreement Relating to Sale From Time to Time of Shares of Common Stock

THOMSON REUTERS
·
25 Feb

FGEN Enhances Shareholder Value with Strategic Share Repurchase

TIPRANKS
·
24 Feb

AstraZeneca Buys FibroGen China for $160 Million to Gain Access to Anemia Drug

MT Newswires Live
·
21 Feb

BUZZ-FibroGen soars on $160 mln China unit sale to AstraZeneca

Reuters
·
20 Feb